Back

Novel oral anticoagulants plus antiplatelet therapy vs. vitamin K antagonists plus antiplatelet therapy in atrial fibrillation patients who underwent percutaneous coronary intervention:a meta-analysis

2 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 5 - Atrial fibrillation and oral anticoagulation 3 Oral Anticoagulation ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Lorraine Grace Sembrana

Philippine Heart Center, Manila (Philippines)

7 More presentations in this session

Presentation thumbnail
Doctor A. Nissen Bonde (Roskilde, DK)
Abstract Slides
Presentation thumbnail
Professor T. Weiss (St. Polten, AT)
Abstract
Presentation thumbnail
Professor E. Klok (Leiden, NL)
Abstract
Presentation thumbnail
Doctor X. Li (Princeton, US)
Abstract Slides
Presentation thumbnail
Doctor E. Choi (Seoul, KR)
Abstract

Access the full session

Session thumbnail
Poster Session 5 - Atrial fibrillation and oral anticoagulation 3

The Event

Event poster

ESC Congress 2019

2 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Session
Stroke prevention in clinical and subclinical atrial fibrillation
thumbnail
Congress Session
Oral anticoagulation in subclinical atrial fibrillation
thumbnail
Congress Presentation
Exploring the feasibility of discontinuing oral anticoagulant therapy in post-ablation atrial fibrillation patients with low stroke risk: a conceptual inquiry

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources